Total Payments
$311.84
2024 Payments
$24.04
Companies
9
Transactions
13
Medicare Patients
5,540
Medicare Billing
$1.8M
Payment Breakdown by Category
Food & Beverage$311.84 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $311.84 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $60.80 | 2 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $51.59 | 2 | $0 (2022) |
| Ortho Dermatologics, a division of Bausch Health US, LLC | $38.73 | 2 | $0 (2024) |
| LEO Pharma Inc. | $38.17 | 2 | $0 (2017) |
| Amgen Inc. | $32.98 | 1 | $0 (2023) |
| PFIZER INC. | $26.05 | 1 | $0 (2023) |
| Mayne Pharma Inc. | $23.40 | 1 | $0 (2018) |
| Misonix Inc | $21.16 | 1 | $0 (2021) |
| Biofrontera Inc. | $18.96 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $24.04 | 1 | Ortho Dermatologics, a division of Bausch Health US, LLC ($24.04) |
| 2023 | $119.83 | 4 | ABBVIE INC. ($60.80) |
| 2022 | $52.66 | 2 | Regeneron Healthcare Solutions, Inc. ($33.70) |
| 2021 | $21.16 | 1 | Misonix Inc ($21.16) |
| 2020 | $14.69 | 1 | Ortho Dermatologics, a division of Bausch Health US, LLC ($14.69) |
| 2018 | $41.29 | 2 | Mayne Pharma Inc. ($23.40) |
| 2017 | $38.17 | 2 | LEO Pharma Inc. ($38.17) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 04/10/2024 | Ortho Dermatologics, a division of Bausch Health US, LLC | Cabtreo (Drug) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Dermatology | ||||||
| 09/29/2023 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $26.36 | General |
| 05/25/2023 | PFIZER INC. | EUCRISA (Drug), CIBINQO, PAXLOVID | Food and Beverage | In-kind items and services | $26.05 | General |
| Category: DERMATOLOGY | ||||||
| 05/24/2023 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $32.98 | General |
| Category: Inflammation | ||||||
| 05/04/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $34.44 | General |
| Category: IMMUNOLOGY | ||||||
| 04/14/2022 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $33.70 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 03/30/2022 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $18.96 | General |
| Category: DERMATOLOGY | ||||||
| 02/17/2021 | Misonix Inc | — | Food and Beverage | In-kind items and services | $21.16 | General |
| 09/21/2020 | Ortho Dermatologics, a division of Bausch Health US, LLC | DUOBRII (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: DERMATOLOGY | ||||||
| 08/24/2018 | Regeneron Healthcare Solutions, Inc. | DUPIXENT DUPILUMAB INJECTION (Biological) | Food and Beverage | In-kind items and services | $17.89 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 02/26/2018 | Mayne Pharma Inc. | DORYX (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: DERMATOLOGY | ||||||
| 08/04/2017 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: DERMATOLOGY | ||||||
| 05/04/2017 | LEO Pharma Inc. | ENSTILAR (Drug) | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: DERMATOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,084 | 1,568 | $1.4M | $342,284 |
| 2022 | 29 | 1,400 | 1,685 | $1.7M | $437,987 |
| 2021 | 27 | 1,353 | 1,640 | $1.5M | $464,687 |
| 2020 | 34 | 1,703 | 2,308 | $1.5M | $594,839 |
Total Patients
5,540
Total Services
7,201
Medicare Billing
$1.8M
Procedure Codes
118
All Medicare Procedures & Services
118 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | Office | 2023 | 222 | 270 | $500,130 | $133,104 | 26.6% |
| 17312 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks | Office | 2023 | 96 | 130 | $146,922 | $44,784 | 30.5% |
| 17313 | Removal and microscopic exam of growth of trunk, arms, or legs, 1-5 tissue blocks | Office | 2023 | 59 | 72 | $126,000 | $37,004 | 29.4% |
| 13132 | Complicated repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet, 2.6-7.5 cm | Office | 2023 | 101 | 110 | $145,256 | $22,248 | 15.3% |
| 15260 | Full thickness skin graft to nose, ears, eyelids, or lips, 20.0 sq cm or less | Office | 2023 | 18 | 18 | $49,950 | $14,625 | 29.3% |
| 14061 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.1-30.0 sq cm | Office | 2023 | 17 | 17 | $46,325 | $13,550 | 29.3% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Office | 2023 | 57 | 66 | $78,540 | $12,561 | 16.0% |
| 14060 | Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | Office | 2023 | 13 | 13 | $27,495 | $7,813 | 28.4% |
| 13152 | Complicated repair of wound of eyelids, nose, ears, or lip, 2.6-7.5 cm | Office | 2023 | 31 | 31 | $42,935 | $6,482 | 15.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 57 | 82 | $20,500 | $5,716 | 27.9% |
| 17314 | Removal and microscopic exam of growth of trunk, arms, or legs, each additional stage, 1-5 tissue blocks | Office | 2023 | 11 | 14 | $15,260 | $4,658 | 30.5% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2023 | 24 | 57 | $10,600 | $4,595 | 43.4% |
| 12032 | Intermediate repair of wound of scalp, underarms, trunk, arms, or legs, 2.6-7.5 cm | Office | 2023 | 25 | 25 | $21,250 | $4,515 | 21.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 75 | 106 | $16,430 | $4,371 | 26.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Office | 2023 | 20 | 22 | $24,750 | $4,002 | 16.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 45 | 65 | $18,850 | $3,600 | 19.1% |
| 29580 | Strapping, unna boot | Office | 2023 | 13 | 63 | $11,340 | $3,080 | 27.2% |
| 13122 | Complicated repair of wound of scalp, arms, or legs, each additional 5.0 cm or less | Office | 2023 | 19 | 25 | $9,000 | $2,671 | 29.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 29 | 29 | $8,729 | $2,418 | 27.7% |
| 11603 | Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm | Office | 2023 | 14 | 16 | $12,320 | $1,878 | 15.2% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 35 | 42 | $7,980 | $1,695 | 21.2% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 17 | 22 | $7,150 | $1,647 | 23.0% |
| 88331 | Pathology examination of specimen during surgery, first tissue block | Office | 2023 | 15 | 19 | $3,610 | $1,619 | 44.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 15 | $5,250 | $1,515 | 28.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 12 | 24 | $3,600 | $970.88 | 27.0% |
About Dr. Alyssa Findley, M.D
Dr. Alyssa Findley, M.D is a Dermatopathology healthcare provider based in Riverside, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2008. The National Provider Identifier (NPI) number assigned to this provider is 1437316676.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alyssa Findley, M.D has received a total of $311.84 in payments from pharmaceutical and medical device companies, with $24.04 received in 2024. These payments were reported across 13 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($311.84).
As a Medicare-enrolled provider, Findley has provided services to 5,540 Medicare beneficiaries, totaling 7,201 services with total Medicare billing of $1.8M. Data is available for 4 years (2020–2023), covering 118 distinct procedure/service records.
Ad
Practice Information
- Specialty Dermatopathology
- Other Specialties MOHS-Micrographic Surgery
- Location Riverside, RI
- Active Since 05/16/2008
- Last Updated 02/27/2024
- Taxonomy Code 207ZD0900X
- Entity Type Individual
- NPI Number 1437316676
Products in Payments
- ENSTILAR (Drug) $38.17
- RINVOQ (Biological) $34.44
- DUPIXENT (Biological) $33.70
- Otezla (Drug) $32.98
- EUCRISA (Drug) $26.05
- Cabtreo (Drug) $24.04
- DORYX (Drug) $23.40
- AMELUZ (Drug) $18.96
- DUPIXENT DUPILUMAB INJECTION (Biological) $17.89
- DUOBRII (Drug) $14.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.